Check Your Claims Before Reviewers Do

 Quick Explanation Copied

 Long Explanation

The Fundamental Attribution Problem

"Xu Yan" is an ambiguous name and the OpenAlex author lookup failed (429 rate limit), so no citation count, h-index, or affiliation timeline could be verified OpenAlex author metrics unavailable. The supplied records plausibly include at least several distinct researchers: Aixin Yan (HKU, efflux pump review), Yan Xu (Westlake, origami robotics; OCC1 provider for ovarian cancer work), and multiple Chinese-affiliated authors. Any author-level score is therefore a portfolio-level proxy, not a verified single-author assessment — a key blindspot.

Strengths Evident From the Work

The strongest entries show genuine methodological rigor: the Myo9b PNAS study combines knockout mice, AFM, SR-SIM, chemotaxis assays, and pharmacological rescue with quantified effect sizes (chemotaxis index 0.47→0.18; lamellipodial fraction 55%→7.9%), and is the only paper with recorded incoming citations (2) PNAS Myo9b knockout study. The Nature Communications origami work (score 9) demonstrates seven decoupled deformation modes with theory-experiment agreement and full fabrication parameters Nature Communications origami robotics paper. The dbGIST resource harmonizes 1,991 samples across 37 centers with public code and in vitro validation of MCM7 dbGIST multi-omics resource.

Weaknesses and Counterpoints

Quality varies sharply: the 2011 ductile cast iron paper (score 5) has only 2 references, no reported sample sizes, no quantitative statistics, and internally contradicts itself (claiming residual Mg thresholds while denying Mg is the direct control) Low-rigor cast iron paper. Recurring limitations across the portfolio: single-strain or single-model systems (CuO/Cr(VI), Pyropia), modest human cohorts (n=12 NP tissues; n=30 rats), cross-species extrapolation (mouse scRNA-seq for human CCA inference), and transcriptomic correlation without functional validation. Positive-result and publication bias likely apply throughout — reported correlations (FCTV r=.15–.50, PGK1 knockdown effects) were not preregistered or replication-confirmed FCTV scale validation study. Citation impact is essentially unverified: incoming citations were recorded for only one of 16 papers.

Verdict With Confidence Limits

As an aggregate, the work reflects a productive, methodologically competent, breadth-over-depth pattern (novelty 6–9, rigor 5–9), peaking in 2023–2026. Confidence is low (≈4/10) for any claim about a single "Xu Yan" individual: disambiguation failure means strengths and weaknesses cannot be reliably assigned. What would change this conclusion: a working OpenAlex/ORCID retrieval confirming one identity, or full-text author lists for each DOI.

 BGPT Author Review

Scientific Quality

Portfolio spans high-impact venues (PNAS, Nature Communications) and methodologically strong studies (genetic knockouts, validated multi-omics resources), but the 2011 cast iron paper (score 5, internal contradiction, no statistics) and the 2011 FCTV survey (student convenience sample) drag the aggregate down. Attribution ambiguity itself caps confidence: multiple researchers likely share the name, and citation metrics could not be retrieved.

Communication Quality

Papers generally report quantitative results, replicates, and methods thoroughly (dbGIST, Myo9b, origami module all document parameters enabling reproduction). Weaknesses include OCR/truncation issues in the cast iron paper and several studies reporting percent changes without raw per-treatment values (Pyropia), reducing clarity for independent readers.

Author Novelty

Several genuinely novel contributions: seven-mode decoupled origami actuation (score 9), ferroptosis execution via caspase-5/GSDME cleavage (score 9), the dbGIST LLM-assisted multi-omics resource (score 9). Lower-novelty entries include a narrative efflux review (6) and conventional observational CKM epidemiology (6). Breadth suggests application-driven novelty rather than a single deep program.

Scientific Rigor

High-rigor work exists (rescue experiments in Myo9b study; cross-dataset validation with in vitro knockdown in dbGIST; theory-experiment agreement in origami). But rigor is inconsistent: the cast iron paper has no reported sample sizes or statistics; transcriptomic claims often lack functional validation (CuO/Cr(VI) study); cross-species inference (mouse scRNA-seq to human CCA) and unpreregistered correlations introduce reporting and selection bias risks.